Evidence map›Paper›PMID 34643411›Full record

ArticleMicrobiology spectrum2021

Ubericin K, a New Pore-Forming Bacteriocin Targeting mannose-PTS.

Thomas F Oftedal, Kirill V Ovchinnikov, Kai A Hestad, Oliver Goldbeck, Davide Porcellato, Judith Narvhus, Christian U Riedel, Morten Kjos, Dzung B Diep

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Design of Novel Saposin-like Bacteriocins Using a Hybrid Approach.Probiotics and antimicrobial proteins · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Microbiology spectrum · 2024
    Article
  10. A novel proteinaceous molecule produced byMicrobiology (Reading, England) · 2023
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Thomas F OftedalFaculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciencesgrid.19477.3c, Ås, Norway.ORCID 0000-0003-4182-3831
Kirill V OvchinnikovFaculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciencesgrid.19477.3c, Ås, Norway.ORCID 0000-0002-1565-3990
Kai A HestadFaculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciencesgrid.19477.3c, Ås, Norway.
Oliver GoldbeckInstitute of Microbiology and Biotechnology, Ulm University, Ulm, Germany.
Davide PorcellatoFaculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciencesgrid.19477.3c, Ås, Norway.
Judith NarvhusFaculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciencesgrid.19477.3c, Ås, Norway.
Christian U RiedelInstitute of Microbiology and Biotechnology, Ulm University, Ulm, Germany.
Morten KjosFaculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciencesgrid.19477.3c, Ås, Norway.ORCID 0000-0003-4448-9082
Dzung B DiepFaculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciencesgrid.19477.3c, Ås, Norway.ORCID 0000-0001-7661-5501
Norwegian University of Life Sciences · NOUniversität Ulm · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bovine mastitis infection in dairy cattle is a significant economic burden for the dairy industry globally. To reduce the use of antibiotics in treatment of clinical mastitis, new alternative treatment options are needed. Antimicrobial peptides from bacteria, also known as bacteriocins, are potential alternatives for combating mastitis pathogens. In search of novel bacteriocins against mastitis pathogens, we screened samples of Norwegian bovine raw milk and found a Streptococcus uberis strain with potent antimicrobial activity toward

Indexed as

AnimalsAnti-Bacterial AgentsBacterial Outer MembraneBacteriocinsCattleCattle DiseasesEnterococcusFemaleLactococcusListeriaMastitis, BovineMicrobial Sensitivity TestsPhosphotransferasesQuorum SensingStreptococcusAnti-Bacterial AgentsBacteriocinsPhosphotransferasesbacteriocinin vitro translationmastitispHluorinpore formationquorum sensingubericin

Identifiers

PMID34643411
PMCPMC8515946
OpenAlexW3205021378

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.